Related references
Note: Only part of the references are listed.Inhibition of the Interleukin-36 Pathway for the Treatment of Generalized Pustular Psoriasis
Herve Bachelez et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Targeting immune cell circuits and trafficking in inflammatory bowel disease
Markus F. Neurath
NATURE IMMUNOLOGY (2019)
Interleukin-36 cytokines alter the intestinal microbiome and can protect against obesity and metabolic dysfunction
Eirini Giannoudaki et al.
NATURE COMMUNICATIONS (2019)
Inhibiting Interleukin 36 Receptor Signaling Reduces Fibrosis in Mice With Chronic Intestinal Inflammation
Kristina Scheibe et al.
GASTROENTEROLOGY (2019)
Extracellular Neutrophil Proteases Are Efficient Regulators of IL-1, IL-33, and IL-36 Cytokine Activity but Poor Effectors of Microbial Killing
Danielle M. Clancy et al.
CELL REPORTS (2018)
Identification of small-molecule elastase inhibitors as antagonists of IL-36 cytokine activation
Graeme P. Sullivan et al.
FEBS OPEN BIO (2018)
Mechanisms of molecular resistance and predictors of response to biological therapy in inflammatory bowel disease
Raja Atreya et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2018)
IL-36R signalling activates intestinal epithelial cells and fibroblasts and promotes mucosal healing in vivo
Kristina Scheibe et al.
GUT (2017)
Mechanisms, Management, and Treatment of Fibrosis in Patients With Inflammatory Bowel Diseases
Florian Rieder et al.
GASTROENTEROLOGY (2017)
IL-36γ signaling controls the induced regulatory T cell-Th9 cell balance via NFkB activation and STAT transcription factors
A. Harusato et al.
MUCOSAL IMMUNOLOGY (2017)
Cutting Edge: IL-36 Receptor Promotes Resolution of Intestinal Damage
Oscar Medina-Contreras et al.
JOURNAL OF IMMUNOLOGY (2016)
Protease inhibition as new therapeutic strategy for GI diseases
Nathalie Vergnolle
GUT (2016)
Increased Expression of Interleukin-36, a Member of the Interleukin-1 Cytokine Family, in Inflammatory Bowel Disease
Atsushi Nishida et al.
INFLAMMATORY BOWEL DISEASES (2016)
IL-36α expression is elevated in ulcerative colitis and promotes colonic inflammation
S. E. Russell et al.
MUCOSAL IMMUNOLOGY (2016)
Cytokines in inflammatory bowel disease
Markus F. Neurath
NATURE REVIEWS IMMUNOLOGY (2014)
IL-36R ligands are potent regulators of dendritic and T cells
Solenne Vigne et al.
BLOOD (2011)
Interleukin-36 (IL-36) Ligands Require Processing for Full Agonist (IL-36α, IL-36β, and IL-36γ) or Antagonist (IL-36Ra) Activity
Jennifer E. Towne et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Interleukin-36-Receptor Antagonist Deficiency and Generalized Pustular Psoriasis
Slaheddine Marrakchi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Share Paper
